
Sionna CLO Liquidates Full Stock Position While Holding Significant Options
Sionna CLO liquidated 10,250 shares for $347k via pre-scheduled plan while retaining 50,935 options. Dual clinical trials expected mid-2026 with $310.3M cash runway through 2028.
SIONbiotechclinical trials